Brand Name | Status | Last Update |
---|---|---|
papaverine hydrochloride | unapproved drug other | 2025-02-11 |
Code | Description |
---|---|
J2440 | Injection, papaverine hcl, up to 60 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Anesthesia | D000758 | — | — | — | — | — | 1 | — | 1 |
Intracranial vasospasm | D020301 | EFO_1000994 | G45.9 | — | — | — | 1 | — | 1 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | — | — | — | 1 | — | 1 |
Infections | D007239 | EFO_0000544 | — | — | — | — | 1 | — | 1 |
Severe acute respiratory syndrome-related coronavirus | D045473 | NCBITaxon_227859 | — | — | — | — | 1 | — | 1 |
Severe acute respiratory syndrome | D045169 | EFO_0000694 | J12.81 | — | — | — | 1 | — | 1 |
Myocarditis | D009205 | — | I51.4 | — | — | — | 1 | — | 1 |
Renal dialysis | D006435 | EFO_0010690 | Z99.2 | — | — | — | 1 | — | 1 |
Virus diseases | D014777 | — | B34 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | — | — | 1 | — | — | 1 |
Traumatic stress disorders | D040921 | — | — | — | — | 1 | — | — | 1 |
Gastroenteritis | D005759 | EFO_1001463 | K52.9 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Erectile dysfunction | D007172 | EFO_0004234 | F52.21 | — | 1 | — | — | 3 | 4 |
Prostatic neoplasms | D011471 | — | C61 | — | 1 | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 2 | — | — | — | — | 2 |
Lung neoplasms | D008175 | — | C34.90 | 1 | — | — | — | 1 | 2 |
Vasculogenic impotence | D018783 | EFO_1001234 | — | 1 | — | — | — | — | 1 |
Prostatic hyperplasia | D011470 | EFO_0000284 | N40 | 1 | — | — | — | — | 1 |
Hyperplasia | D006965 | EFO_0000536 | — | 1 | — | — | — | — | 1 |
Schizophrenia | D012559 | EFO_0000692 | F20 | 1 | — | — | — | — | 1 |
Cognitive dysfunction | D060825 | — | G31.84 | 1 | — | — | — | — | 1 |
Cognition disorders | D003072 | — | — | 1 | — | — | — | — | 1 |
Neurocognitive disorders | D019965 | — | F09 | 1 | — | — | — | — | 1 |
Carcinoma | D002277 | — | C80.0 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Patellofemoral pain syndrome | D046788 | EFO_1001092 | — | — | — | — | — | 5 | 5 |
Hip osteoarthritis | D015207 | EFO_1000786 | M16 | — | — | — | — | 5 | 5 |
Motor activity | D009043 | EFO_0003940 | — | — | — | — | — | 3 | 3 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | — | 3 | 3 |
Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | — | — | 3 | 3 |
Oligospermia | D009845 | — | N46.1 | — | — | — | — | 2 | 2 |
Peroneal neuropathies | D020427 | EFO_1001102 | G57.3 | — | — | — | — | 2 | 2 |
Spinal stenosis | D013130 | EFO_0007490 | M48.0 | — | — | — | — | 1 | 1 |
Penile neoplasms | D010412 | — | C60 | — | — | — | — | 1 | 1 |
Joint diseases | D007592 | — | M12.9 | — | — | — | — | 1 | 1 |
Drug common name | Papaverine |
INN | — |
Description | Papaverine is a benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum. It has a role as a vasodilator agent and an antispasmodic drug. It is a benzylisoquinoline alkaloid, a member of isoquinolines and a dimethoxybenzene. |
Classification | Small molecule |
Drug class | spasmolytic agents (papaverine type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC |
PDB | — |
CAS-ID | 58-74-2 |
RxCUI | — |
ChEMBL ID | CHEMBL19224 |
ChEBI ID | 28241 |
PubChem CID | 4680 |
DrugBank | DB01113 |
UNII ID | — |